Stay updated on CAD106 and CNP520 in At-Risk Alzheimer's Clinical Trial
Sign up to get notified when there's something new on the CAD106 and CNP520 in At-Risk Alzheimer's Clinical Trial page.

Latest updates to the CAD106 and CNP520 in At-Risk Alzheimer's Clinical Trial page
- CheckyesterdayChange DetectedThe site’s footer revision identifier changed from v3.7.0 to v3.7.1 while the study page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedAccess to the study record has been replaced by a 403 Forbidden page, removing the detailed trial information and sponsor/location data from the page.SummaryDifference19%

- Check22 days agoChange DetectedThe page's revision label was updated from v3.6.6 to v3.7.0 in the footer, indicating a software update. No study content or navigation elements were altered.SummaryDifference0.0%

- Check36 days agoChange DetectedThe page shows a new revision tag v3.6.6, replacing the previous v3.6.5, indicating a small metadata update to the page.SummaryDifference0.0%

- Check43 days agoChange DetectedAdded 2015 ( U.S. NIH Grant/Contract ), Generation Program web site, Novartis (Novartis Pharmaceuticals), and Helpful Links Provided by to the page, providing funding attribution, program context, and external resources for the study.SummaryDifference0.1%

- Check57 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5 on the page. This reflects a new page revision in the site's content management system.SummaryDifference0.0%

Stay in the know with updates to CAD106 and CNP520 in At-Risk Alzheimer's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CAD106 and CNP520 in At-Risk Alzheimer's Clinical Trial page.